Figures in parentheses refer to results during the corresponding period of the previous yearThe Group's sales amounted to 64.8 (61.2) MSEK for the third quarter of the year.The Group's net result tota ...
Endo, Inc. announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene and betamethasone dipropionate) in Canada ...